Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00514_DB06684> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00514_DB06684 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00514_DB06684 label "DDI between Dextromethorphan and Vilazodone - Consideration should be given to avoiding the concomitant use of dextromethorphan and selective serotonin reuptake inhibitors (SSRI). Monitor for toxic effects of dextromethorphan (eg, CNS, Cardiovascular) if an SSRI is initiated or the dose is increased. SSRIs, other than fluoxetine and paroxetine, may be safer alternatives due to lesser CYP2D6 inhibition; however, the mechanism for the interaction is not fully understood, and caution is still advised. [drugbank_resource:DB00514_DB06684]" assertion.
- drugbank_resource:DB00514_DB06684 identifier "drugbank_resource:DB00514_DB06684" assertion.
- drugbank_resource:DB00514_DB06684 title "DDI between Dextromethorphan and Vilazodone - Consideration should be given to avoiding the concomitant use of dextromethorphan and selective serotonin reuptake inhibitors (SSRI). Monitor for toxic effects of dextromethorphan (eg, CNS, Cardiovascular) if an SSRI is initiated or the dose is increased. SSRIs, other than fluoxetine and paroxetine, may be safer alternatives due to lesser CYP2D6 inhibition; however, the mechanism for the interaction is not fully understood, and caution is still advised." assertion.